Chief Operating Officer, Jonathan Lanfear, is an accomplished biopharmaceutical executive with more than 25 years of experience in the life sciences industry and has demonstrated distinct success in creating and driving strategies, building and developing teams, establishing R&D partnerships, and creating new business opportunities. Prior to joining HiberCell, Jonathan was a Principal at Lanfear Advisors LLC, where he provided Corporate Strategy and Operations consultancy services to public and private sector biotech and bio/pharmaceutical companies. Prior to establishing his consulting practice in 2020, he was the Global Head of R&D Business Development at Takeda Pharmaceuticals, based in Cambridge MA.
Before joining Takeda in 2011, Jonathan spent approximately eight years at Pfizer Inc as a Senior Director and Transactions Lead in the Worldwide Business Development, Strategy, & Innovation (WWBDS&I) organization based in New York. His prior roles also include Biotechnology Equity Research at AG Edwards/Wachovia and Team Leader, GMP Operations and Downstream Processing at Searle/Pharmacia (prior to the company’s acquisition by Pfizer). Over his career, Jonathan has led hundreds of transactions of all types, integrated acquired entities, lead operations, and managed strategic alliances/partnerships. He holds a Bachelor’s degree in Chemical Engineering and a Master’s degree in Bioengineering, both from the University of Michigan (Ann Arbor), along with an MBA from Washington University (St. Louis). Jonathan is also a member of the Board of Directors of Molecular Templates, an oncology focused, publicly traded company based in New Jersey.